These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34119877)

  • 1. Placental growth factor as a diagnostic tool for placental mediated fetal growth restriction.
    Shinar S; Tigert M; Agrawal S; Parks WA; Kingdom JC
    Pregnancy Hypertens; 2021 Aug; 25():123-128. PubMed ID: 34119877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental growth factor as an indicator of fetal growth restriction in late-onset small-for-gestational age pregnancies.
    Anderson N; De Laat M; Benton S; von Dadelszen P; McCowan L
    Aust N Z J Obstet Gynaecol; 2019 Feb; 59(1):89-95. PubMed ID: 29851029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction.
    Benton SJ; McCowan LM; Heazell AE; Grynspan D; Hutcheon JA; Senger C; Burke O; Chan Y; Harding JE; Yockell-Lelièvre J; Hu Y; Chappell LC; Griffin MJ; Shennan AH; Magee LA; Gruslin A; von Dadelszen P
    Placenta; 2016 Jun; 42():1-8. PubMed ID: 27238707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble fms-like tyrosine kinase to placental growth factor ratio in different stages of early-onset fetal growth restriction and small for gestational age.
    Garcia-Manau P; Mendoza M; Bonacina E; Garrido-Gimenez C; Fernandez-Oliva A; Zanini J; Catalan M; Tur H; Serrano B; Carreras E
    Acta Obstet Gynecol Scand; 2021 Jan; 100(1):119-128. PubMed ID: 32860218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of placental biomarkers and fetoplacental Dopplers in predicting likely placental pathology in early and late fetal growth restriction - A prospective study.
    Hong J; Crawford K; Daly M; Clifton V; da Silva Costa F; Perkins AV; Matsika A; Lourie R; Kumar S
    Placenta; 2024 Oct; 156():20-29. PubMed ID: 39232442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of angiogenetic biomarkers in the detection of early onset fetal growth restriction.
    Giorgione V; Ramnarine S; Malik A; Bhide A
    Eur J Obstet Gynecol Reprod Biol; 2024 Aug; 299():91-95. PubMed ID: 38850897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of circulating maternal placenta growth factor levels and sonographic evaluation of patients with abnormal first trimester screening analytes.
    Ashwal E; Keunen J; Ravichandran A; Ellul K; Agrawal S; Hobson SR; Windrim RC; Kingdom JC
    Prenat Diagn; 2023 Jul; 43(8):1044-1055. PubMed ID: 36738445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The accuracy of Fetoplacental Doppler in distinguishing between growth restricted and constitutionally small fetuses.
    Ashwal E; Ferreira F; Mei-Dan E; Aviram A; Sherman C; Zaltz A; Kingdom J; Melamed N
    Placenta; 2022 Mar; 120():40-48. PubMed ID: 35189547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal vascular malformation in the placenta is an indicator for fetal growth restriction irrespective of neonatal birthweight.
    Hendrix MLE; Bons JAP; Alers NO; Severens-Rijvers CAH; Spaanderman MEA; Al-Nasiry S
    Placenta; 2019 Nov; 87():8-15. PubMed ID: 31520871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. sFlt-1/PlGF ratio and timing of delivery in early-onset fetal growth restriction with antegrade umbilical artery flow.
    Quezada MS; Rodríguez-Calvo J; Villalaín C; Gómez-Arriaga PI; Galindo A; Herraiz I
    Ultrasound Obstet Gynecol; 2020 Oct; 56(4):549-556. PubMed ID: 31840879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Customized birth-weight centiles and placenta-related fetal growth restriction.
    Melamed N; Hiersch L; Aviram A; Keating S; Kingdom JC
    Ultrasound Obstet Gynecol; 2021 Mar; 57(3):409-416. PubMed ID: 33073889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypes of maternal vascular malperfusion placental pathology and adverse pregnancy outcomes: A retrospective cohort study.
    Zur RL; McLaughlin K; Aalto L; Jiang Y; Huszti E; Parks WT; Kingdom JC
    BJOG; 2024 Oct; 131(11):1515-1523. PubMed ID: 38725333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental pathology lesions: International Society for Ultrasound in Obstetrics and Gynecology vs Society for Maternal-Fetal Medicine fetal growth restriction definitions.
    Rodriguez-Sibaja MJ; Lopez-Diaz AJ; Valdespino-Vazquez MY; Acevedo-Gallegos S; Amaya-Guel Y; Camarena-Cabrera DM; Lumbreras-Marquez MI
    Am J Obstet Gynecol MFM; 2024 Aug; 6(8):101422. PubMed ID: 38969177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Doppler ultrasound at time of diagnosis of late-onset fetal growth restriction in predicting adverse perinatal outcome: prospective cohort study.
    Rizzo G; Mappa I; Bitsadze V; Słodki M; Khizroeva J; Makatsariya A; D'Antonio F
    Ultrasound Obstet Gynecol; 2020 Jun; 55(6):793-798. PubMed ID: 31343783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of small for gestational age neonates: screening by maternal factors, fetal biometry, and biomarkers at 35-37 weeks' gestation.
    Ciobanu A; Rouvali A; Syngelaki A; Akolekar R; Nicolaides KH
    Am J Obstet Gynecol; 2019 May; 220(5):486.e1-486.e11. PubMed ID: 30707967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the PLGF in the prediction of the outcome in pregnancies with a small for gestational age fetus.
    Souka AP; Antsaklis P; Tassias K; Chatziioannou MA; Papamihail M; Daskalakis G
    Arch Gynecol Obstet; 2024 Jul; 310(1):237-243. PubMed ID: 37837546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implementation of the sFlt-1/PlGF ratio to identify preeclampsia and fetal growth restriction: A prospective cohort study.
    Herraiz I; Simón E; Gómez-Arriaga PI; Quezada MS; García-Burguillo A; López-Jiménez EA; Galindo A
    Pregnancy Hypertens; 2018 Jul; 13():279-285. PubMed ID: 30177066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical evaluation of placental growth factor in routine practice in high-risk women presenting with suspected pre-eclampsia and/or fetal growth restriction.
    Ormesher L; Johnstone ED; Shawkat E; Dempsey A; Chmiel C; Ingram E; Higgins LE; Myers JE
    Pregnancy Hypertens; 2018 Oct; 14():234-239. PubMed ID: 29559205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competing-risks model for prediction of small-for-gestational-age neonate from maternal characteristics, serum pregnancy-associated plasma protein-A and placental growth factor at 11-13 weeks' gestation.
    Papastefanou I; Wright D; Lolos M; Anampousi K; Mamalis M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Mar; 57(3):392-400. PubMed ID: 32936500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Placental Basis of Fetal Growth Restriction.
    Zur RL; Kingdom JC; Parks WT; Hobson SR
    Obstet Gynecol Clin North Am; 2020 Mar; 47(1):81-98. PubMed ID: 32008673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.